This Biotech 60%. Healthcare Stocks See Fresh $11M Bet
A top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
Explore various ways to monetize your skills and effectively manage your debt. Learn how to turn your expertise into extra income.
19,574 articlesA top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
When a top executive sells nearly 5,000 shares of Alpha and Omega Semiconductor, investors pause. This article breaks...
Deckers Outdoor has posted a jaw-dropping 1,000% gain over the past decade, powered by Ugg and Hoka. But with shiftin...
GLD's fee drag and tax treatment can erode bullion gains even as gold prices rise. A closer look at cheaper peers and...
Oklo stock just popped on news that the Department of Energy opened talks with multiple firms. This article breaks do...
A growing number of retirees moved cash into Treasury bills to lock in near-4% yields. But the tax system on Social S...
Silver isn’t just a shiny metal—it’s a complex mix of industrial demand and investor sentiment. This article breaks d...
This week, the market eyeing the Fed's preferred inflation gauge could steer the next move in stocks. If the gauge sh...
A landmark NYC case shows how a nonprofit steered funds through hidden vendors, inflating costs and obscuring ownersh...
Apple is rumored to launch AI wearable devices in the coming years. This article explains how these smart devices cou...
Anthropic's Claude Opus Here: Opus 4.8 brings sharper reasoning and tighter alignment without a price change. This de...
Rivian just raised guidance, signaling progress in its production ramp. Yet the stock reaction was bearish, underscor...